Prevalence of diabetes, hypertension and cardiovascular disease in patients with COVID-19: a systematic review and meta-analysis

Abstract

Right now, there is small data on the prevalence of predominant chronic diseases. In addition, it is important for healthcare providers to know the underlying diseases in COVID-19 infected patients. The aim of present systematic review and meta-analysis was conducted on the Prevalence of diabetes, Hypertension and cardiovascular diseases in patients with COVID-19. MEDLINE, PubMed, Cochrane Library, Embase, ISI, google scholar were the electronic databases that used to perform a systematic literature between 2010 to March 2020. Endnote X9 software was used for managing the electronic titles. Searches were performed using these keywords: “COVID-19 OR novel coronavirus OR 2019-nCoV OR Corona Virus Disease”, “diabetes”,” Hypertension”,” cardiovascular disease”. The present systematic review was done based on the main consideration of PRISMA Statement–Preferred Reporting Items for Systematic Reviews and Meta-analysis. The result of the electronic and manual search was a total of 168 potentially relevant titles and abstracts but finally nine studies were included. Meta-analysis reported that 0.19 (95% CI: 0.06-0.13) of SARS-CoV-2 cases were Diabetes. Regarding the I2 index, which was calculated to be 66.9% and the Chi-square test, there was significant heterogeneity between the resources (P=0.01). Hypertensions were the most prevalent underlying diseases in COVID-19 patients.

References

  • Adda A, Mohammed C, Djamel S, Abdelkader B, Khalladi M (2016) Remote Sensing of Evapotranspiration in a Southern Mediterranean Forest. Application to Bissa Forest, Algeria. The International Journal of Biotechnology, 5(3): 35-44.
  • Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P, Rodríguez-Morales AJ (2020) The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI). Travel medicine and infectious disease, 33: 101567.
  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y¸et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223): 507-513.
  • Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C (2015). Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC medicine, 13(1): 1-12.
  • Emami A, Javanmardi F, Pirbonyeh N, Akbari A (2020) Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of academic emergency medicine, 8(1).
  • Gorbalenya A, Baker SC, Baric RS (2020) Severe acute respiratory syndrome related coronavirus: The species and its viruses a statement of the coronavirus study group.
  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18): 1708-1720.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223): 497-506.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223): 497-506.
  • Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents, 105924.
  • Larsen D, Dinero R, Asiago-Reddy E, Green H, Lane S, Shaw A, et al. (2020) A review of infectious disease surveillance to inform public health action against the novel coronavirus SARS-CoV-2.
  • Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. (2020) Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 novel coronavirus infections outside Wuhan, China. medRxiv.
  • Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal.
  • McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. (2020) Epidemiology of Covid-19 in a long-term care facility in King County, Washington. New England Journal of Medicine, 382(21): 2005-2011.
  • Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 102433.
  • Thompson R (2020) Pandemic potential of 2019-nCoV. Lancet Infect Dis, 20(3): 280.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11): 1061-1069.
  • Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. (2020) Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis, 10.
  • Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ¸Ma CL, et al. (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ, 368.
  • Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. (2020) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy.
  • Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International journal of infectious diseases, 92: 214-217.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.